Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

The gene NM_026333 slows down aging by affecting the NCX1 pathway and could be targeted for anti-aging treatments.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Substance from human umbilical cord blood cells promotes hair growth.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Udenafil may help hair grow by activating certain stem cells.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.